Case Report of a Novel NFkB Mutation in a Lymphoproliferative Disorder Patient.
Danandeh K, Jabbari P, Rayzan E, Zoghi S, Shahkarami S, Heredia RJ, Krolo A, Shamsian BS, Boztug K, Rezaei N.
Danandeh K, et al. Among authors: shamsian bs.
Endocr Metab Immune Disord Drug Targets. 2022;22(10):1040-1046. doi: 10.2174/1871530322666220407091356.
Endocr Metab Immune Disord Drug Targets. 2022.
PMID: 35392793